» Articles » PMID: 2568911

Isolation of 10 Cyclosporine Metabolites from Human Bile

Overview
Specialty Pharmacology
Date 1989 May 1
PMID 2568911
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Ten metabolites of cyclosporine were isolate from the ethyl ether extract of bile from four liver transplant patients receiving cyclosporine. Two of the metabolites were unique and previously unidentified. Liquid-liquid partitioning into diethyl ether with subsequent defatting with n-hexane was used for the initial extraction from bile. Separation of the individual metabolites (A-J) was performed using a Sephadex LH-20 column and a gradient high performance liquid chromatographic method. The molecular weights of the isolated metabolites were determined by fast atom bombardment/mass spectrometry. Gas chromatography with mass spectrometric amino acid analysis was also used to identify the amino acid composition and the hydroxylation position of metabolites A, B, C, D, and G. Proton nuclear magnetic resonance spectra were utilized to distinguish the chemical shifts of N-CH3 singlets and NH doublets of metabolites A, B, C, and D. Metabolites A, E, F, H, I, and J were reported previously in human urine and animal bile. Metabolites C and D are dihydroxylated compounds which cannot be clearly described as previously isolated compounds. Metabolites B and G are novel metabolites with a mass fragment which corresponded to a loss of 131 Da from the protonated molecular ion (MH+) in the fast atom bombardment/mass spectrometry, suggesting that the double bond in amino acid 1 has been modified. Metabolites B and G were primarily isolated from the bile of one of the liver transplant patients which contained abnormally high concentrations of these two metabolites. The method described is an efficient procedure for isolating milligram quantities of the major metabolites with greater than 95% purity.

Citing Articles

Pharmacometabolomics Enables Real-World Drug Metabolism Sciences.

Nijdam F, Hof M, Blokzijl H, Bakker S, Hak E, Hopfgartner G Metabolites. 2025; 15(1).

PMID: 39852382 PMC: 11767479. DOI: 10.3390/metabo15010039.


Des3PI: a fragment-based approach to design cyclic peptides targeting protein-protein interactions.

Delaunay M, Ha-Duong T J Comput Aided Mol Des. 2022; 36(8):605-621.

PMID: 35932404 DOI: 10.1007/s10822-022-00468-z.


Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.

ElJebari H, Gaies E, Ben Fradj N, Jebabli N, Salouage I, Trabelsi S Eur J Clin Pharmacol. 2012; 68(11):1517-24.

PMID: 22527344 DOI: 10.1007/s00228-012-1275-9.


Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase.

Shet M, Fisher C, Holmans P, Estabrook R Proc Natl Acad Sci U S A. 1993; 90(24):11748-52.

PMID: 8265621 PMC: 48061. DOI: 10.1073/pnas.90.24.11748.


Pharmacokinetic drug interactions with cyclosporin (Part II).

Yee G, McGuire T Clin Pharmacokinet. 1990; 19(5):400-15.

PMID: 2268987 DOI: 10.2165/00003088-199019050-00004.

References
1.
Maurer G, Lemaire M . Biotransformation and distribution in blood of cyclosporine and its metabolites. Transplant Proc. 1986; 18(6 Suppl 5):25-34. View

2.
Hashem H, Venkataramanan R, Burckart G, Makowka L, Starzl T, Fu E . Identification of the Aldehydic Metabolites. Transplant Proc. 2010; 20(1 Suppl 1):176-178. PMC: 3008815. View

3.
Lensmeyer G, Wiebe D, CARLSON I . Deposition of nine metabolites of cyclosporine in human tissues, bile, urine, and whole blood. Transplant Proc. 1988; 20(2 Suppl 2):614-22. View

4.
Hartman N, Trimble L, Vederas J, Jardine I . An acid metabolite of cyclosporine. Biochem Biophys Res Commun. 1985; 133(3):964-71. DOI: 10.1016/0006-291x(85)91230-6. View

5.
Hartman N, Jardine I . The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporine metabolites. Drug Metab Dispos. 1987; 15(5):661-4. View